血管內(nèi)皮生長因子受體2(VEGFR2)單克隆抗體
Monoclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
CD309; FLK1; VEGFR; KDR; A Type III Receptor Tyrosine Kinase; Kinase Insert Domain Receptor; Kinase Insert Domain Receptor; Fetal Liver Kinase-1
- 編號MAB367Hu21
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)2-2#
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPB367Hu01-血管內(nèi)皮生長因子受體2(VEGFR2)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/mL
- 且適物種Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠)
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 446 ¥ 1042 ¥ 1488 ¥ 3720 ¥ 14880
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
FITC staining on IF; Sample: Human MCF7 cell; Primary Ab: 20ug/ml Mouse Anti-Human VEGFR2 Antibody Second Ab: 5μg/ml FITC-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu18)
-
IHC圖
-
IHC圖
-
WB圖
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對VEGFR2的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別VEGFR2。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| APB367Hu61 | 血管內(nèi)皮生長因子受體2(VEGFR2)活性蛋白 | Cell?culture;?Activity?Assays. |
| EPB367Hu61 | 血管內(nèi)皮生長因子受體2(VEGFR2)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB367Hu01 | 血管內(nèi)皮生長因子受體2(VEGFR2)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPB367Hu01 | 血管內(nèi)皮生長因子受體2(VEGFR2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB367Hu01 | 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB367Hu81 | 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAB367Hu71 | 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| FAB367Hu51 | 抗血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體(別藻藍(lán)蛋白標(biāo)記) | FCM |
| MAB367Hu23 | 血管內(nèi)皮生長因子受體2(VEGFR2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB367Hu26 | 血管內(nèi)皮生長因子受體2(VEGFR2)單克隆抗體 | WB; IHC; ICC; IP. |
| RAB367Hu21 | 血管內(nèi)皮生長因子受體2(VEGFR2)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
| MAB367Hu22 | 血管內(nèi)皮生長因子受體2(VEGFR2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB367Hu24 | 血管內(nèi)皮生長因子受體2(VEGFR2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB367Hu21 | 血管內(nèi)皮生長因子受體2(VEGFR2)單克隆抗體 | WB; IHC; ICC; IP. |
| FAB367Hu32 | 抗血管內(nèi)皮生長因子受體2(VEGFR2)單克隆抗體(別藻藍(lán)蛋白/花青染料cy7標(biāo)記) | FCM |
| FAB367Hu82 | 抗血管內(nèi)皮生長因子受體2(VEGFR2)單克隆抗體(異硫氰酸熒光素標(biāo)記) | Flow cytometry. |
| HEB367Hu | 血管內(nèi)皮生長因子受體2(VEGFR2)檢測試劑盒(酶聯(lián)免疫吸附試驗法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEB367Hu | 血管內(nèi)皮生長因子受體2(VEGFR2)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB367Hu | 血管內(nèi)皮生長因子受體2(VEGFR2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSB367Hu01 | 血管內(nèi)皮生長因子受體2(VEGFR2)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | 自己動手制作ELISA試劑盒的主要材料 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| APMIS | Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway [PubMed: 23398358] |
| Acta Biomater | Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study [PubMed: 26689470] |
| Acta Biomaterialia | Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study [Pubmed:26689470] |
| Journal?of?Cellular?Physiology | A?Human?3D?In?Vitro?Model?to?Assess?the?Relationship?Between?Osteoporosis?and?Disseminationto?Bone?of?Breast?Cancer?Tumor?Cells. [pubmed:27925188] |
| Regenerative Biomaterials | The directional migration and differentiation of mesenchymal stem cells toward vascular endothelial cells stimulated by biphasic calcium phosphate ceramic [10.1093/rb/rbx028] |
| International Journal of Immunopathology and Pharmacology | VEGF-R2 and TNF-R1 expression and cytokine production by samples of mammary adenocarcinomas and correlations with histopathological parameters of these?… [Pubmed:29985074] |
| JOURNAL OF DERMATOLOGICAL TREATMENT | Effect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris [Pubmed: 32043381] |
| Journal of Genetic Engineering and Biotechnology | Encapsulated VEGF 121-PLA microparticles promote angiogenesis in human endometrium stromal cells [33523322] |
| Mol Cell Biochem | Intuitive repositioning of an anti-depressant drug in combination with tivozanib: precision medicine for breast cancer therapy [34324118] |
| BMC Nephrol | Effect of subacute poisoning with lambdacyhalothrin on vascular endothelial growth factor 2 receptor in mice kidneys [Pubmed:35643467] |
留言咨詢
